1-2 of 2
Hayley S Wall
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TTT-3002 Is a Novel FLT3 Tyrosine Kinase Inhibitor That Has the Potential to Overcome Some of the Limitations of Current FLT3 Inhibitors in Treatment of Acute Myeloid Leukemia

Hayley S Wall, B.S., Bao Nguyen, M.S., Li Li, PhD, Sarah M Greenblatt, PhD, Patrick Brown, MD, Mark J. Levis, MD, PhD, Donald Small, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 866.
https://doi.org/10.1182/blood.V120.21.866.866
Published: 2012
Journal Articles

Generation of a FLT3 Kinase Domain Point Mutation (D835Y equivalent) Knock-in Mouse Confers Less Aggressive Disease Compared with FLT3 Internal Tandem Duplication (ITD) Mice

Emily Bailey, DVM, Li Li, PhD, David Huso, D.V.M., Ph.D., Hayley S Wall, Donald Small, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 924.
https://doi.org/10.1182/blood.V118.21.924.924
Published: 2011